Royce & Associates LP Meridian Bioscience Inc Transaction History

Royce & Associates LP

$10.3 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $10,684 - $11,452	343 Added 0.2%	169,512 $5.63 Million
Q3 2022 Nov 03, 2022	SELL	$30.9 - $33.55 $46.6 Million - $50.6 Million	-1,508,085 Reduced 89.91%	169,169 $5.33 Million
Q2 2022 Aug 04, 2022	SELL	$23.75 - $31.69 $8.08 Million - $10.8 Million	-340,119 Reduced 16.86%	1,677,254 $51 Million
Q1 2022 May 05, 2022	SELL	$19.97 - $26.94 $3.56 Million - $4.81 Million	-178,477 Reduced 8.13%	2,017,373 $52.4 Million
Q4 2021 Feb 07, 2022	BUY	$17.46 - $21.61 $1.1 Million - $1.37 Million	63,267 Added 2.97%	2,195,850 $44.8 Million
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $1.56 Million - $2.03 Million	90,084 Added 4.41%	2,132,583 $41 Million
Q2 2021 Aug 06, 2021	BUY	$18.01 - $28.32 $22 Million - $34.5 Million	1,219,795 Added 148.27%	2,042,499 $45.3 Million
Q1 2021 May 10, 2021	BUY	$19.76 - $29.89 $2.92 Million - $4.42 Million	147,870 Added 21.91%	822,704 $21.6 Million
Q4 2020 Feb 08, 2021	BUY	$15.73 - $21.66 $5.49 Million - $7.56 Million	349,259 Added 107.27%	674,834 $12.6 Million
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $3.35 Million - $6.54 Million	247,757 Added 318.38%	325,575 $5.53 Million
Q2 2020 Aug 07, 2020	BUY	$7.84 - $23.29 $14,739 - $43,785	1,880 Added 2.48%	77,818 $1.81 Million
Q1 2020 May 12, 2020	BUY	$5.57 - $11.5 $114,519 - $236,440	20,560 Added 37.13%	75,938 $638,000
Q4 2019 Feb 06, 2020	SELL	$7.9 - $10.14 $613,253 - $787,137	-77,627 Reduced 58.36%	55,378 $541,000
Q3 2019 Nov 13, 2019	BUY	$9.17 - $12.01 $510,704 - $668,872	55,693 Added 72.04%	133,005 $1.26 Million
Q2 2019 Aug 12, 2019	SELL	$10.88 - $17.6 $15,765 - $25,502	-1,449 Reduced 1.84%	77,312 $918,000
Q1 2019 May 09, 2019	SELL	$15.51 - $17.61 $988,219 - $1.12 Million	-63,715 Reduced 44.72%	78,761 $1.39 Million
Q4 2018 Feb 11, 2019	SELL	$14.52 - $19.72 $75,837 - $102,997	-5,223 Reduced 3.54%	142,476 $2.47 Million
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $10,528 - $11,592	709 Added 0.48%	147,699 $2.2 Million
Q2 2018 Aug 09, 2018	BUY	$13.8 - $16.8 $6,182 - $7,526	448 Added 0.31%	146,990 $2.34 Million
Q1 2018 May 14, 2018	SELL	$13.8 - $16.2 $1,393 - $1,636	-101 Reduced 0.07%	146,542 $2.08 Million
Q4 2017 Feb 09, 2018	SELL	$13.55 - $15.8 $69,199 - $80,690	-5,107 Reduced 3.37%	146,643 $2.05 Million
Q3 2017 Nov 13, 2017	SELL	$13.45 - $14.35 $82,636 - $88,166	-6,144 Reduced 3.89%	151,750 $2.17 Million
Q2 2017 Aug 07, 2017	BUY	N/A	157,894	157,894 $2.49 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account